|
注册号: Registration number: |
ChiCTR2400090229 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-26 09:42:34 |
|
注册时间: Date of Registration: |
2024-09-26 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
中国老年人群流感疫苗接种的干预研究 |
|
Public title: |
Intervention Study on Influenza Vaccination Among the Elderly in China |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中国老年人群流感疫苗接种的干预研究 |
|
Scientific title: |
Intervention Study on Influenza Vaccination Among the Elderly in China |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
林浩 |
研究负责人: |
曹望楠 |
|
Applicant: |
Hao Lin |
Study leader: |
Wangnan Cao |
|
申请注册联系人电话: Applicant telephone: |
+86 186 1052 8952 |
研究负责人电话:
Study leader's |
+86 152 1081 7312 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
linhao@bjmu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
wangnancao@bjmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市海淀区学院路38号 |
研究负责人通讯地址: |
北京市海淀区学院路38号 |
|
Applicant address: |
No.38 Xueyuan Road, Haidian District, Beijing |
Study leader's address: |
No.38 Xueyuan Road, Haidian District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
100191 |
研究负责人邮政编码: Study leader's postcode: |
100191 |
|
申请人所在单位: |
北京大学医学部 |
||
|
Applicant's institution: |
Peking University Health Science Center |
||
|
研究负责人所在单位: |
北京大学医学部 |
||
|
Affiliation of the Leader: |
Peking University Health Science Center |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
IRB00001052-24090 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Peking University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-09-13 00:00:00 | ||
|
伦理委员会联系人: |
宋艳双 |
||
|
Contact Name of the ethic committee: |
Yanshuang Song |
||
|
伦理委员会联系地址: |
北京市海淀区学院路38号 |
||
|
Contact Address of the ethic committee: |
No.38 Xueyuan Road, Haidian District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 8280 5751 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京大学公共卫生学院 |
||||||||||||||||||||||
|
Primary sponsor: |
School of Public Health, Peking University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市海淀区学院路38号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.38 Xueyuan Road, Haidian District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
北京市自然科学基金-海淀原始创新联合基金(L222029) |
||||||||||||||||||||||
|
Source(s) of funding: |
Joint Research Fund for Beijing Natural Science Foundation and Haidian Original Innovation (L222029) |
||||||||||||||||||||||
|
研究疾病: |
流感 |
||||||||||||||||||||||
|
Target disease: |
Influenza |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
整群随机分组 |
||||||||||||||||||||||
|
Study design: |
Cluster randomization |
||||||||||||||||||||||
|
研究目的: |
本研究的目的是设计基于信息-动机-行为技巧(IMB)模型的行为干预,以及经济激励措施,促进中国老年人群接种流感疫苗,并通过随机对照试验验证行为干预和经济激励单独和联合实施的有效性。 |
||||||||||||||||||||||
|
Objectives of Study: |
The objective of this study is to design the IMB-based behavioral intervention and economic incentives for promoting self-paid influenza vaccination among the Chinese elderly, and conduct a randomized controlled trial to validate the separate and combined effectiveness of behavior interventions and economic incentives. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1) 由医生评估,存在不适宜接种流感疫苗的身体健康情况; 2)存在可能影响到知情同意过程的认知障碍或其他严重疾病 |
||||||||||||||||||||||
|
Exclusion criteria: |
a) having a physical health condition deemed unsuitable for influenza vaccination as assessed by a physician; b) having cognitive impairment or other severe illness that may affect the informed consent process. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-09-20 00:00:00至 To 2025-02-28 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-09-20 00:00:00 至 To 2024-10-20 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
在每个社区内将采用简单随机抽样方法招募100名参与者,从各社区卫生服务中心获取基本公共卫生服务名单,研究助理将使用计算机软件SPSS 21.0生成随机数字序列,由社区卫生服务中心工作人员进行抽取。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Within each selected community, a simple random sampling method will be employed to recruit 100 participants. The sampling frame will be drawn from the community health centers' lists of individuals receiving basic public health services. Research assistants will utilize the computer software SPSS 21.0 to generate a random number sequence, which will then be used by community health center staff to select the participants. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
结果评估人员、数据录入人员和分析数据的统计人员不知晓群组的分配情况 |
|
Blinding: |
The outcome assessors, data entry personnel and statisticians who analyse the data will be blinded throughout the study as they are not part of the team who delivers intervention or manage the project |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后向负责人邮件申请公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the end of the study, data will be shared upon e-mails to PI on request |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |